191 related articles for article (PubMed ID: 26983014)
1. Is MTHFR 677 C>T Polymorphism Clinically Important in Polycystic Ovarian Syndrome (PCOS)? A Case-Control Study, Meta-Analysis and Trial Sequential Analysis.
Carlus SJ; Sarkar S; Bansal SK; Singh V; Singh K; Jha RK; Sadasivam N; Sadasivam SR; Gireesha PS; Thangaraj K; Rajender S
PLoS One; 2016; 11(3):e0151510. PubMed ID: 26983014
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
3. Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.
Fu LY; Dai LM; Li XG; Zhang K; Bai Y
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():56-61. PubMed ID: 24192663
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome.
Nsrallah AA; Abd-El Fatah AH; Ahmed HS
J Gene Med; 2019 Apr; 21(4):e3076. PubMed ID: 30743312
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
Xiong Y; Bian C; Lin X; Wang X; Xu K; Zhao X
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639550
[TBL] [Abstract][Full Text] [Related]
6. Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women.
Feng W; Zhang Y; Pan Y; Zhang Y; Liu M; Huang Y; Xiao Y; Mo W; Jiao J; Wang X; Tian D; Yang L; Ma Y
Reprod Biol Endocrinol; 2021 Jan; 19(1):5. PubMed ID: 33407572
[TBL] [Abstract][Full Text] [Related]
7. [Association of methylenetetrahydrofolate reductase gene polymorphisms with polycystic ovary syndrome].
Qi Q; Zhang H; Yu M; Wang X; Wang Z; Xu L; Wang J; Mu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):400-4. PubMed ID: 26037361
[TBL] [Abstract][Full Text] [Related]
8. Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with genetic susceptibility to polycystic ovary syndrome: A PRISMA-compliant meta-analysis.
Zhu X; Hong X; Chen L; Xuan Y; Huang K; Wang B
Gene; 2019 Nov; 719():144079. PubMed ID: 31454542
[TBL] [Abstract][Full Text] [Related]
9. Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome.
Choi SW; Gu BH; Ramakrishna S; Park JM; Baek KH
Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):85-8. PubMed ID: 19427093
[TBL] [Abstract][Full Text] [Related]
10. Is there an association between the development of metabolic syndrome in PCOS patients and the C677T MTHFR gene polymorphism?
Ożegowska K; Bogacz A; Bartkowiak-Wieczorek J; Seremak-Mrozikiewicz A; Pawelczyk L
Ginekol Pol; 2016; 87(4):246-53. PubMed ID: 27321094
[TBL] [Abstract][Full Text] [Related]
11. Significant association between methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: A meta-analysis update.
Li Y; Zhu H; Liu M; Zeng Z; Zeng Y; Xu X; Ye M
Medicine (Baltimore); 2020 Jan; 99(4):e18720. PubMed ID: 31977861
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis on associations of FTO, MTHFR and TCF7L2 polymorphisms with polycystic ovary syndrome.
Wang X; Wang K; Yan J; Wu M
Genomics; 2020 Mar; 112(2):1516-1521. PubMed ID: 31470081
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome.
Karadeniz M; Erdogan M; Zengi A; Eroglu Z; Tamsel S; Olukman M; Saygili F; Yilmaz C
Endocrine; 2010 Aug; 38(1):127-33. PubMed ID: 20960113
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
Bagos PG
Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome.
Orio F; Palomba S; Di Biase S; Colao A; Tauchmanova L; Savastano S; Labella D; Russo T; Zullo F; Lombardi G
J Clin Endocrinol Metab; 2003 Feb; 88(2):673-9. PubMed ID: 12574198
[TBL] [Abstract][Full Text] [Related]
16. Methylenotetrahydrololate reductase A1298C and C677T polymorphisms and adverse pregnancy outcome in women with PCOS.
Szafarowska M; Segiet A; Jerzak MM
Neuro Endocrinol Lett; 2016; 37(2):141-6. PubMed ID: 27179578
[TBL] [Abstract][Full Text] [Related]
17. Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.
Karimi-Zarchi M; Moghimi M; Abbasi H; Hadadan A; Salimi E; Morovati-Sharifabad M; Akbarian-Bafghi MJ; Zare-Shehneh M; Mosavi-Jarrahi A; Neamatzadeh H
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2569-2577. PubMed ID: 31554347
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M
Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325
[TBL] [Abstract][Full Text] [Related]
19. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.
Klerk M; Verhoef P; Clarke R; Blom HJ; Kok FJ; Schouten EG;
JAMA; 2002 Oct 23-30; 288(16):2023-31. PubMed ID: 12387655
[TBL] [Abstract][Full Text] [Related]
20. The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis.
Mei Q; Zhou D; Gao J; Shen S; Wu J; Guo L; Liang Z
BMC Cancer; 2012 Oct; 12():467. PubMed ID: 23057736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
